CIK: 1120477 - Address: C/O Protagonist Therapeutics, Inc., 7707 Gateway Blvd., Suite 140, Newark, CA 94560-1160
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/11/24 16:30
6/7/24
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-1,23235.190-35-6515D
4/2/24 20:29
4/1/24
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-70828.310-25-4550D
3/1/24 20:46
3/1/24
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-94931.620-30-5575D
12/15/23 16:30
12/13/23
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-1,50620.080-75-12534D
10/19/23 16:55
10/18/23
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOM.d254.21061609D
8/24/22 18:15
8/23/22
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOM.d844.210203604D
5/4/22 20:33
5/4/22
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOM.d664.210163584D
4/26/22 21:34
4/26/22
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOM.d1264.210306568D
4/14/22 20:09
4/14/22
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOTP,CEOM.d641.890347538D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact